Commure in the Crosshairs

Nobody’s having a longer week than Commure after STAT published a scalding investigation into the company’s growth (at all costs) engine. Turns out it’s a lot easier to be a happy customer when you’re getting paid to be one.

Here’s the backstory. Commure set out in 2020 to build an AI operating system for healthcare that takes power away from payors and hands it back to clinicians. 

  • CEO Tanay Tandon summed up the Robin Hood pitch on the YC podcast by saying he’d love a world where UnitedHealth’s market cap is a fifth of what it is today, but every doctor is a millionaire.
  • Fast forward a few years and $800 million VC dollars (acquisitions are expensive), and Commure’s grown into a $7B juggernaut helping 130+ health systems automate administrative tasks.

Now comes the investigation. STAT revealed that Commure offers large incentives to clinics and other parties that refer its products to new prospects.

  • One physical therapy clinic’s contract required it to refer $750k of new business within a year, or face a $66k “referral obligation fee.”
  • Affiliate partners earn 2% of any contracts they bring in, so they have plenty of motivation from both carrots and sticks.
  • The catch is that STAT found some especially enthusiastic customers that deliver booth testimonials in company quarter-zips, have Commure email addresses, and hang out in internal Slack channels.

That gets shaky when you have mixed reviews. Some customers credit the platform with driving massive collection boosts. Others either “don’t have a positive thing to say about it” or have absolute horror stories. 

  • The article cites particularly unflattering reviews from a Wyoming rehab clinic that fell $500k behind on collections after handing the keys to Commure, as well as an Arizona FQHC that watched $1M in dental claims get denied without receiving a single notification about the issue.

That could be a problem. Former federal prosecutors told STAT that paying for referrals to products funded by Medicare or Medicaid doesn’t sit well with the anti-kickback statute.

  • This isn’t the DOJ’s first rodeo, and some major players have been lassoed into settlements over kickback allegations.

Commure’s response? Everything is fine, and everybody is doing it. The company called its referral practices industry standard, chalked the complaints up to a small minority of customers, and lashed out at STAT for giving readers a distorted view of the business.

The Takeaway

Commure’s internal mantra is apparently “speed above all else,” so maybe a few not-technically-kickbacks are just the cost of doing business. A jury might not see it that way, but then again Commure isn’t on trial (at least not yet).

Mispricing the RCM Bundle

Recovering consultant Andrew Tsang is back with another top tier analysis exploring why healthcare’s revenue cycle management bundle is currently mispriced. 

Great bundles lead to great unbundling. The term “unbundling” was first coined in a 2010 Tumblr post that applied the concept to Craigslist, a patchwork homepage of loosely related categories waiting to be peeled off as specialized startups.

  • AirBnB eventually took housing, Indeed took jobs, and dating apps took personals. Investors were standing by with checkbooks in hand every time. 

RCM is healthcare’s Craigslist. It’s a $300B monster of about a dozen different steps that exist to process the disagreement when payors and providers can’t agree on what care is worth.

  • RCM is practically begging to be broken into its component parts (prior auth, clinical documentation, denials), but the same investors funding the unbundling thesis are also the ones writing huge checks to fuse the wedges back together.

That’s because Craigslist isn’t linked like RCM. You don’t need a new love interest to get a new couch, and you don’t need a new couch to get a new love interest. Although it couldn’t hurt.

  • With RCM, optimize coding and the patient’s bill goes up. Optimize collections and patients defer future care. Every optimization at one step ripples through the others.

Hospital execs know this. They’re not buying best-of-breed point solutions, they’re consolidating onto platforms that cover the full lifecycle, and vendors are behaving accordingly.

  • Tsang argues that RCM vendors are rational actors that are being pushed to acquire nearby wedges rather than build them, and you don’t have to look much further than Waystar or Smarter Technologies to find evidence to support that.
  • “The payor-provider fight is structurally dysfunctional, and that dysfunction rewards positioning over performance.”

RCM isn’t getting unbundled, it’s getting rolled up. When IT budgets get cut, CFOs pick the partner who covers enough of the arc to be worth keeping.

  • The worse the market gets, the more valuable broad coverage becomes, and the RCM platform moat continues compounding. That’s the state of the RCM market.

The Takeaway

Tsang makes a compelling case that the RCM vendors that survive the next decade won’t be the ones that reduce the claims disagreement. They’ll be the ones that own the channel for it.

Get the top digital health stories right in your inbox